Novartis Ag (NVS) EPS (Basic) (2009 - 2026)
Novartis Ag (NVS) posted EPS (Basic) of $1.71 for Q2 2026, down 92.05% sequentially from $21.55 in Q2 2025, and down 92.05% YoY from $21.55 in Q2 2025.
Novartis Ag (NVS) EPS (Basic) (2009 - 2026) Analysis & Trends
Novartis Ag has reported EPS (Basic) for 18 years, with the latest figure at $1.71 in Q2 2026.
- Quarterly EPS (Basic) fell 92.05% year-over-year to $1.71 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.71 (down 96.12% YoY) and the FY2025 annual result came in at $7.21, down 66.96% from the prior year.
- EPS (Basic) eased to $1.71 in Q2 2026 per NVS's latest filing, from $21.55 in the prior quarter.
- Over five years, EPS (Basic) peaked at $15158.9 in Q1 2022 and troughed at $0.07 in Q1 2023.
- A 5-year average of $1277.3 and a median of $21.69 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) jumped 146.53% in 2022, then slumped 100.0% in 2023.
- Over 5 years, EPS (Basic) stood at $27.21 in 2022, then fell by 17.42% to $22.47 in 2023, then decreased by 2.86% to $21.83 in 2024, then fell by 1.25% to $21.55 in 2025, then plunged by 92.05% to $1.71 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $1.71, $21.55, and $21.83 for Q2 2026, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 1.62 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 4.40 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 0.29 |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 |
| Jun 30, 2025 | 21.55 |
| Dec 31, 2024 | 21.83 |
| Jun 30, 2024 | 20.53 |
| Dec 31, 2023 | 22.47 |
| Sep 30, 2023 | 0.12 |
| Jun 30, 2023 | 24.89 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 27.21 |
| Sep 30, 2022 | 0.11 |
| Jun 30, 2022 | 28.63 |
| Mar 31, 2022 | 15,158.88 |
| Dec 31, 2021 | 30.16 |
| Sep 30, 2021 | 0.62 |
| Jun 30, 2021 | 24.09 |
| Mar 31, 2021 | 6,149.02 |
| Dec 31, 2020 | 24.86 |
| Sep 30, 2020 | 7,864.30 |
| Jun 30, 2020 | 23.51 |
| Mar 31, 2020 | 0.08 |